Investigation of carvedilol-evoked Ca²⁺ movement and death in human oral cancer cells

References

• Chakraborty S, Shukla D, Mishra B, Singh S. Clinical updates on carvedilol: a first choice beta-blocker in the treatment of cardiovascular diseases. Expert Opin Drug Metab Toxicol 2010, 6, 237–250.
   PubMed Web of Science ®Google Scholar
• Stafylas PC, Sarafidis PA. Carvedilol in hypertension treatment. Vasc Health Risk Manag 2008, 4, 23–30.
   PubMedGoogle Scholar
• Carreira RS, Monteiro P, Gon Alves LM, Providência LA. Carvedilol: just another beta-blocker or a powerful cardioprotector? Cardiovasc Hematol Disord Drug Targets 2006, 6, 257–266.
   Google Scholar
• Doughty RN, White HD. Carvedilol: use in chronic heart failure. Expert Rev Cardiovasc Ther 2007, 5, 21–31.
   Google Scholar
• Dandona P, Ghanim H, Brooks DP. Antioxidant activity of carvedilol in cardiovascular disease. J Hypertens 2007, 25, 731–741.
   PubMed Web of Science ®Google Scholar
• Cheng J, Niwa R, Kamiya K, Toyama J, Kodama I. Carvedilol blocks the repolarizing K+ currents and the L-type Ca2+ current in rabbit ventricular myocytes. Eur J Pharmacol 1999, 376, 189–201.
   Google Scholar
• Korantzopoulos P, Galaris D, Papaioannides D, Siogas K. The possible role of oxidative stress in heart failure and the potential of antioxidant intervention. Med Sci Monit 2003, 9, RA120–RA125.
   Google Scholar
• Deng C, Yu X, Kuang S, Zhang W, Zhou Z, Zhang K, Qian W, Shan Z, Yang M, Wu S, Lin S. Effects of carvedilol on transient outward and ultra-rapid delayed rectifier potassium currents in human atrial myocytes. Life Sci 2007, 80, 665–671.
   PubMed Web of Science ®Google Scholar
• Kajiwara K, Yanagita T, Nakashima Y, Wada A, Izumi F, Yanagihara N. Differential effects of short and prolonged exposure to carvedilol on voltage-dependent Na+ channels in cultured bovine adrenal medullary cells. J Pharmacol Exp Ther 2002, 302, 212–218.
   Google Scholar
• Duan JJ, Wang Q, Deng CY, Kuang SJ, Chen RZ, Tao L. Effects of carvedilol on delayed rectifier and transient inactivating potassium currents in rat hippocampal CA1 neurons. Clin Exp Pharmacol Physiol 2010, 37, 996–1003.
   Google Scholar
• Hayashi T, De Velasco MA, Saitou Y, Nose K, Nishioka T, Ishii T, Uemura H. Carvedilol protects tubular epithelial cells from ischemia–reperfusion injury by inhibiting oxidative stress. Int J Urol 2010, 17, 989–995.
   PubMedGoogle Scholar
• Berridge MJ. Elementary and global aspects of calcium signalling. J Physiol (Lond) 1997, 499 (Pt 2), 291–306.
   Google Scholar
• Berridge MJ. Inositol trisphosphate and calcium signalling. Nature 1993, 361, 315–325.
   PubMed Web of Science ®Google Scholar
• Bootman MD, Berridge MJ, Roderick HL. Calcium signalling: more messengers, more channels, more complexity. Curr Biol 2002, 12, R563–R565.
   PubMed Web of Science ®Google Scholar
• Annunziato L, Amoroso S, Pannaccione A, Cataldi M, Pignataro G, D’Alessio A, Sirabella R, Secondo A, Sibaud L, Di Renzo GF. Apoptosis induced in neuronal cells by oxidative stress: role played by caspases and intracellular calcium ions. Toxicol Lett 2003, 139, 125–133.
   PubMed Web of Science ®Google Scholar
• Cheng JS, Huang CC, Chou CT, Jan CR. Mechanisms of carvedilol-induced [Ca2+]i rises and death in human hepatoma cells. Naunyn Schmiedebergs Arch Pharmacol 2007, 376, 185–194.
   Google Scholar
• Liu CP, Chiang HT, Jan CR. Novel effect of carvedilol on Ca2+ movement in renal tubular cells. Biochem Pharmacol 2002, 64, 1777–1784.
   Google Scholar
• Liu CP, Jan CR. Effect of carvedilol on Ca2+ movement and cytotoxicity in human MG63 osteosarcoma cells. Basic Clin Pharmacol Toxicol 2004, 95, 59–65.
   Google Scholar
• Tseng LL, Shu SS, Kuo CC, Chou CT, Hsieh YD, Chu ST, Chi CC, Liang WZ, Ho CM, Jan CR. Effect of methoxychlor on Ca2+ handling and viability in OC2 human oral cancer cells. Basic Clin Pharmacol Toxicol 2011, in press.
   Google Scholar
• Kuo LN, Huang CJ, Fang YC, Huang CC, Wang JL, Lin KL, Chu ST, Chang HT, Chien JM, Su HH, Chi CC, Chen WC, Tsai JY, Liao WC, Tseng LL, Jan CR. Effect of thimerosal on Ca2+ movement and viability in human oral cancer cells. Hum Exp Toxicol 2009, 28, 301–308.
   PubMed Web of Science ®Google Scholar
• Huang C, Huang C, Cheng J, Liu S, Chen I, Tsai J, Chou C, Tseng P, Jan C. Fendiline-evoked [Ca2+]i rises and non-Ca2+-triggered cell death in human oral cancer cells. Hum Exp Toxicol 2009, 28, 41–48.
   PubMed Web of Science ®Google Scholar
• Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985, 260, 3440–3450.
   PubMed Web of Science ®Google Scholar
• Merritt JE, Jacob R, Hallam TJ. Use of manganese to discriminate between calcium influx and mobilization from internal stores in stimulated human neutrophils. J Biol Chem 1989, 264, 1522–1527.
   PubMed Web of Science ®Google Scholar
• Thastrup O, Cullen PJ, Drøbak BK, Hanley MR, Dawson AP. Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase. Proc Natl Acad Sci USA 1990, 87, 2466–2470.
   PubMed Web of Science ®Google Scholar
• Thompson AK, Mostafapour SP, Denlinger LC, Bleasdale JE, Fisher SK. The aminosteroid U-73122 inhibits muscarinic receptor sequestration and phosphoinositide hydrolysis in SK-N-SH neuroblastoma cells. A role for Gp in receptor compartmentation. J Biol Chem 1991, 266, 23856–23862.
   PubMed Web of Science ®Google Scholar
• Christofi FL. Purinergic receptors and gastrointestinal secretomotor function. Purinergic Signal 2008, 4, 213–236.
   PubMed Web of Science ®Google Scholar
• Tsien RY. New calcium indicators and buffers with high selectivity against magnesium and protons: design, synthesis, and properties of prototype structures. Biochemistry 1980, 19, 2396–2404.
   PubMed Web of Science ®Google Scholar
• Harper JL, Camerini-Otero CS, Li AH, Kim SA, Jacobson KA, Daly JW. Dihydropyridines as inhibitors of capacitative calcium entry in leukemic HL-60 cells. Biochem Pharmacol 2003, 65, 329–338.
   PubMed Web of Science ®Google Scholar
• Ishikawa J, Ohga K, Yoshino T, Takezawa R, Ichikawa A, Kubota H, Yamada T. A pyrazole derivative, YM-58483, potently inhibits store-operated sustained Ca2+ influx and IL-2 production in T lymphocytes. J Immunol 2003, 170, 4441–4449.
   PubMed Web of Science ®Google Scholar
• Jiang N, Zhang ZM, Liu L, Zhang C, Zhang YL, Zhang ZC. Effects of Ca2+ channel blockers on store-operated Ca2+ channel currents of Kupffer cells after hepatic ischemia/reperfusion injury in rats. World J Gastroenterol 2006, 12, 4694–4698.
   PubMed Web of Science ®Google Scholar
• Quinn T, Molloy M, Smyth A, Baird AW. Capacitative calcium entry in guinea pig gallbladder smooth muscle in vitro. Life Sci 2004, 74, 1659–1669.
   PubMed Web of Science ®Google Scholar
• Pecivová J, Macicková T, Lojek A, Gallova L, Cíz M, Nosál’ R, Holománová D. In vitro effect of carvedilol on professional phagocytes. Pharmacology 2007, 79, 86–92.
   Google Scholar
• Hobbs RP, Amargo EV, Somasundaram A, Simpson CL, Prakriya M, Denning MF, Green KJ. The calcium ATPase SERCA2 regulates desmoplakin dynamics and intercellular adhesive strength through modulation of PKCα signaling. FASEB J 2011, 25, 990–1001.
   PubMed Web of Science ®Google Scholar
• Harper MT, Molkentin JD, Poole AW. Protein kinase C alpha enhances sodium-calcium exchange during store-operated calcium entry in mouse platelets. Cell Calcium 2010, 48, 333–340.
   Google Scholar
• Luo AT, Luo HY, Hu XW, Gao LL, Liang HM, Tang M, Hescheler J. Hyposmotic challenge modulates function of L-type calcium channel in rat ventricular myocytes through protein kinase C. Acta Pharmacol Sin 2010, 31, 1438–1446.
   Google Scholar
• Spallarossa P, Garibaldi S, Altieri P, Fabbi P, Manca V, Nasti S, Rossettin P, Ghigliotti G, Ballestrero A, Patrone F, Barsotti A, Brunelli C. Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. J Mol Cell Cardiol 2004, 37, 837–846.
   PubMed Web of Science ®Google Scholar
• Túnez I, Collado JA, Medina FJ, Muñoz MC, Gordillo R, Sampedro C, Moyano MJ, Feijóo M, Muntané J, Montilla P. Protective effect of carvedilol on oxidative stress induced by okadaic acid in N1E-115 cells. Pharmacol Res 2006, 54, 241–246.
   Google Scholar
• Yamagata K, Ichinose S, Tagami M. Amlodipine and carvedilol prevent cytotoxicity in cortical neurons isolated from stroke-prone spontaneously hypertensive rats. Hypertens Res 2004, 27, 271–282.
   Google Scholar
• Das S, Bhattacharyya S, Ghosh S, Majumdar S. TNF-alpha induced altered signaling mechanism in human neutrophil. Mol Cell Biochem 1999, 197, 97–108.
   PubMed Web of Science ®Google Scholar
• Matuszyk J, Kobzdej M, Ziolo E, Kalas W, Kisielow P, Strzadala L. Thymic lymphomas are resistant to Nur77-mediated apoptosis. Biochem Biophys Res Commun 1998, 249, 279–282.
   PubMed Web of Science ®Google Scholar
• Krämer BK, Ress KM, Erley CM, Risler T. Pharmacokinetic and blood pressure effects of carvedilol in patients with chronic renal failure. Eur J Clin Pharmacol 1992, 43, 85–88.
   PubMed Web of Science ®Google Scholar
• Gehr TW, Tenero DM, Boyle DA, Qian Y, Sica DA, Shusterman NH. The pharmacokinetics of carvedilol and its metabolites after single and multiple dose oral administration in patients with hypertension and renal insufficiency. Eur J Clin Pharmacol 1999, 55, 269–277.
   PubMed Web of Science ®Google Scholar
• Bouchard NC, Forde J, Hoffman RS. Carvedilol overdose with quantitative confirmation. Basic Clin Pharmacol Toxicol 2008, 103, 102–103.
   PubMed Web of Science ®Google Scholar